Ketamine Revisited : : New Insights into NMDA Inhibitors /

Ketamine Revisited : : New Insights into NMDA Inhibitors / / edited by Nieves Saiz-Sapena, Manuel Granell Gil.

Show other versions (1)

In the past, ketamine was considered a dangerous medication with the potential for abuse as a recreational drug. Healthcare providers were warned of its dangers and taught to fear its use. With this book, we hope to eliminate any fear and misgivings associated with this drug. It can be a useful medi...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Gil, Manuel Granell,
Saiz-Sapena, Nieves,
Place / Publishing House:London : : IntechOpen,, 2022.
©2022
Year of Publication:2022
Language:English
Physical Description:1 online resource (300 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993581429604498
ctrlnum (CKB)5700000000338630
(NjHacI)995700000000338630
(EXLCZ)995700000000338630
collection bib_alma
record_format marc
spelling Ketamine Revisited : New Insights into NMDA Inhibitors / edited by Nieves Saiz-Sapena, Manuel Granell Gil.
Ketamine Revisited
London : IntechOpen, 2022.
©2022
1 online resource (300 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on: online resource; title from PDF title page (IntechOpen, viewed March 25, 2023).
In the past, ketamine was considered a dangerous medication with the potential for abuse as a recreational drug. Healthcare providers were warned of its dangers and taught to fear its use. With this book, we hope to eliminate any fear and misgivings associated with this drug. It can be a useful medication in many situations, some of which we describe herein. This book discusses the use of ketamine in anesthesia, pain disorders, depression, palliative care, and trauma situations. It also examines ketamine usage in developing countries.
Includes bibliographical references and index.
1. Introduction -- 2. Ketamine and its molecular effects -- 2.1 Immediate effects -- 2.2 Disruption of NMDA channel functions by ketamine -- 2.3 Ketamine possesses delayed effects -- 3. Psychotomimetic effects of ketamine -- 4. Hypnosis -- 5. Pain -- 5.1 Control of chronic pain -- 6. Antidepressant effects of ketamine -- 7. Conclusion -- Funding -- Declaration of interest -- References.
Ketamine.
1-83962-792-1
Gil, Manuel Granell, editor.
Saiz-Sapena, Nieves, editor.
language English
format eBook
author2 Gil, Manuel Granell,
Saiz-Sapena, Nieves,
author_facet Gil, Manuel Granell,
Saiz-Sapena, Nieves,
author2_variant m g g mg mgg
n s s nss
author2_role TeilnehmendeR
TeilnehmendeR
title Ketamine Revisited : New Insights into NMDA Inhibitors /
spellingShingle Ketamine Revisited : New Insights into NMDA Inhibitors /
1. Introduction -- 2. Ketamine and its molecular effects -- 2.1 Immediate effects -- 2.2 Disruption of NMDA channel functions by ketamine -- 2.3 Ketamine possesses delayed effects -- 3. Psychotomimetic effects of ketamine -- 4. Hypnosis -- 5. Pain -- 5.1 Control of chronic pain -- 6. Antidepressant effects of ketamine -- 7. Conclusion -- Funding -- Declaration of interest -- References.
title_sub New Insights into NMDA Inhibitors /
title_full Ketamine Revisited : New Insights into NMDA Inhibitors / edited by Nieves Saiz-Sapena, Manuel Granell Gil.
title_fullStr Ketamine Revisited : New Insights into NMDA Inhibitors / edited by Nieves Saiz-Sapena, Manuel Granell Gil.
title_full_unstemmed Ketamine Revisited : New Insights into NMDA Inhibitors / edited by Nieves Saiz-Sapena, Manuel Granell Gil.
title_auth Ketamine Revisited : New Insights into NMDA Inhibitors /
title_alt Ketamine Revisited
title_new Ketamine Revisited :
title_sort ketamine revisited : new insights into nmda inhibitors /
publisher IntechOpen,
publishDate 2022
physical 1 online resource (300 pages)
contents 1. Introduction -- 2. Ketamine and its molecular effects -- 2.1 Immediate effects -- 2.2 Disruption of NMDA channel functions by ketamine -- 2.3 Ketamine possesses delayed effects -- 3. Psychotomimetic effects of ketamine -- 4. Hypnosis -- 5. Pain -- 5.1 Control of chronic pain -- 6. Antidepressant effects of ketamine -- 7. Conclusion -- Funding -- Declaration of interest -- References.
isbn 1-83962-793-X
1-83962-792-1
callnumber-first R - Medicine
callnumber-subject RD - Surgery
callnumber-label RD86
callnumber-sort RD 286 K4 K483 42022
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 615 - Pharmacology & therapeutics
dewey-full 615.781
dewey-sort 3615.781
dewey-raw 615.781
dewey-search 615.781
work_keys_str_mv AT gilmanuelgranell ketaminerevisitednewinsightsintonmdainhibitors
AT saizsapenanieves ketaminerevisitednewinsightsintonmdainhibitors
AT gilmanuelgranell ketaminerevisited
AT saizsapenanieves ketaminerevisited
status_str n
ids_txt_mv (CKB)5700000000338630
(NjHacI)995700000000338630
(EXLCZ)995700000000338630
carrierType_str_mv cr
is_hierarchy_title Ketamine Revisited : New Insights into NMDA Inhibitors /
author2_original_writing_str_mv noLinkedField
noLinkedField
_version_ 1764995726687862784
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02044nam a2200337 i 4500</leader><controlfield tag="001">993581429604498</controlfield><controlfield tag="005">20230325123059.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230325s2022 enk ob 001 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-83962-793-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5700000000338630</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995700000000338630</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995700000000338630</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RD86.K4</subfield><subfield code="b">.K483 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">615.781</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Ketamine Revisited :</subfield><subfield code="b">New Insights into NMDA Inhibitors /</subfield><subfield code="c">edited by Nieves Saiz-Sapena, Manuel Granell Gil.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Ketamine Revisited </subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (300 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF title page (IntechOpen, viewed March 25, 2023).</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In the past, ketamine was considered a dangerous medication with the potential for abuse as a recreational drug. Healthcare providers were warned of its dangers and taught to fear its use. With this book, we hope to eliminate any fear and misgivings associated with this drug. It can be a useful medication in many situations, some of which we describe herein. This book discusses the use of ketamine in anesthesia, pain disorders, depression, palliative care, and trauma situations. It also examines ketamine usage in developing countries.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">1. Introduction -- 2. Ketamine and its molecular effects -- 2.1 Immediate effects -- 2.2 Disruption of NMDA channel functions by ketamine -- 2.3 Ketamine possesses delayed effects -- 3. Psychotomimetic effects of ketamine -- 4. Hypnosis -- 5. Pain -- 5.1 Control of chronic pain -- 6. Antidepressant effects of ketamine -- 7. Conclusion -- Funding -- Declaration of interest -- References.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Ketamine.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-83962-792-1</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gil, Manuel Granell,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saiz-Sapena, Nieves,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-04-15 12:45:17 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-12-05 16:10:45 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5343036890004498&amp;Force_direct=true</subfield><subfield code="Z">5343036890004498</subfield><subfield code="8">5343036890004498</subfield></datafield></record></collection>

Similar Items